Choroid plexus tumor
Disease Information
Research & Innovation
Dana-Farber/Children's Hospital Cancer Center is a member of the Pediatric Oncology Therapeutic Experimental Investigators Consortium (POETIC), a collaborative clinical research group offering experimental therapies to patients with relapsed (returning) or refractory (resistant to treatment) disease. It is also the New England Phase I Center of the Children's Oncology Group and a member of the Department of Defense Neurofibromatosis Clinical Trial Consortium.
We are home to the only dedicated pediatric low-grade astrocytoma program, the Pediatric Low-Grade Astrocytoma (PLGA) Research Program.
| Clinical trials |
|---|
| Find out more about the innovative clinical trials available at Dana-Farber/Children’s Hospital Cancer Center. |
